Who owns ISIS Pharmaceuticals?

Key details on ISIS Pharmaceuticals (Ticker: ISIS)

Who owns ISIS Pharmaceuticals?

Is ISIS a good stock to own? Find out who bought ISIS Pharmaceuticals, who sold ISIS Pharmaceuticals (ISIS) stock, and who holds a large position in ISIS Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 17.55M $758.32M March 31, 2014
ClearBridge Advisors 8.24M $283.85M June 30, 2014
Artisan Partners Limited Partnership 7.57M $260.82M June 30, 2014
Vanguard 7.27M $250.44M June 30, 2014
BB Biotech AG 6.71M $231.04M June 30, 2014
Waddell & Reed Financial 5.36M $184.78M June 30, 2014
Columbia Wanger Asset Management 5.08M $71.52M Sept. 30, 2012
BlackRock Fund Advisors 4.13M $142.41M June 30, 2014
BlackRock Institutional Trust Company, N.A. 3.21M $110.57M June 30, 2014
T. Rowe Price Associates 2.77M $95.30M June 30, 2014
STATE STREET CORPORATION 2.41M $82.94M June 30, 2014
BVF 2.16M $25.94M June 30, 2012
Jennison Associates 2.03M $69.93M June 30, 2014
SUSQUEHANNA INTERNATIONAL 2.01M $86.92M March 31, 2014
Franklin Resources 1.95M $67.23M June 30, 2014
Gail Mannix 1.94M $83.86M March 31, 2014
Tocqueville Asset Management 1.86M $64.18M June 30, 2014
LORD, ABBETT & CO 1.78M $66.81M Sept. 30, 2013
NORTHERN TRUST 1.67M $66.34M Dec. 31, 2013